We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Myelin-Producing Cells Restore Nerve Function in Mice

By Biotechdaily staff writers
Posted on 21 Jan 2004
By introducing myelin-producing cells in widespread areas of the brain in mice, scientists have been able to restore proper nerve function in nearly the entire brain more efficiently than was previously possible, offering the possibility of treatment for demyelinating diseases. The findings were reported in the January 2004 issue of Nature Medicine.

Myelin is a fatty substance that covers nearly all the nerve cells in the body and helps signals in the nervous system go from one point to another. When myelin breaks down, electrical signals degrade. This can result in a number of disorders as well as such diseases as Canavan disease in children and multiple sclerosis (MS). Currently, demyelinating diseases are permanent, with no available therapy.

The investigators remyelinated the mice by injecting highly purified human progenitor cells, which ultimately evolved into the cells that make myelin, called oligodendrocytes. They studied 44 mice born without any myelin wrapped around their brain cells. Within 24 hours, they injected the mice and found that the cells quickly migrated throughout the brain, developing into oligodendrocytes and producing myelin. The team found that adult human cells were much more adept at settling into the brain, becoming oligodendrocytes and producing myelin, than fetal cells.

"The results are much better than we expected,” said team leader Steven Goldman, M.D., Ph.D., professor of neurology at the University of Rochester Medical Center (NY, USA; www.rochester.edu). "The percentage of cells in this experiment that began producing myelin is extraordinary, probably thousands of times as many as in previous experiments.”




Related Links:
University of Rochester

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Automatic CLIA Analyzer
Shine i9000

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
21 Jan 2004  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
21 Jan 2004  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
21 Jan 2004  |   BioResearch